.png)
2024 | Aug 26
Pneuma Systems Corporation eliminates legacy problems to transform the standard of care for patients and nurses by leveraging patented technologies, modern components and cutting-edge software. The FDA has added Pneuma to its selective Safer Technologies Program (STeP) for Medical Devices, which accelerates the regulatory review for medical devices that offer significant advantages over currently available options.
2024 | Aug 12
Pneuma Systems Corporation is pleased to announce the acceptance of its PneumaFlow™ Controller and Administration Sets into the U.S. Food and Drug Administration's Safer Technologies Program (STeP) for Medical Devices. STeP is an accelerated regulatory review process to give patients more timely access to innovation by expediting development, assessment, and review of 510(k) documentation.
2023 | Feb 10
Imagine if the entertainment industry never took a disruptive leap to completely redesign tech products. Television sets would weigh 600 pounds and you’d get maybe 20 channels. Now pivot to medical devices. Most infusion pumps in the market today were designed in the 1980s and were successful. But there’s no initiative from big organizations to take a big leap towards redesign and improvement. Innovation is dying.
​
In this week’s episode, sponsored by TrackableMed, Jeffrey Carlisle, CEO of Pneuma Systems, joins us to share his perspective on innovation in MedTech. We also discuss how technology contributes to the shortage of nurses, the importance of understanding the customer’s experience, and one simple step everyone can take to invite innovation into their organization.
2022 | Nov 8
Pneuma is breaking a lot of ground with innovations in technology, user experiences, workflow, and economics for infusion therapy. The company has added Dr. Roxie Mooney to its Board to help guide this process. Her career has been based on the study of healthcare innovations and she draws from hundreds of relevant experiences to help guide the company. She is the author of the highly acclaimed How Health Innovators Maximize Market Success.
2022 | Aug 8
Infusion pumps have a long history of recalls; in fact, the leading infusion pumps are in some form of recall more often than not. Pneuma offers a control system that is "self-aware", so that any failures can be detected prior to causing harm. To fully exploit this capability, Pneuma sought out a world expert in reliability to challenge its design. Adam Bahret accepted the challenge and is leading the way to design and test an infusion device with unprecedented proven reliability.
2022 | Jun 20
Stan Chamallas joins Pneuma to improve infusion processes in the home care market which he helped to establish decades ago.
2022 | Jun 7
John Toomey joins the Pneuma team to manage its intellectual property portfolio and oversee a novel regulatory path aimed at post market surveillance and measurement of improved processes.
2022 | Apr 25
Centers of Infusion Excellence are part of the "Empowering Care" theme in which Pneuma relentlessly removes the obstacles that are between a nurse and a patient.
2022 | Apr 7
Pneuma collaborates with West Pharmaceutical Services, a century-old supplier of containers and delivery systems for medications.
2022 | Mar 7
Ivenix, a company founded by Pneuma CEO Jeffrey Carlisle, has been acquired by a market leader seeking a foothold in the US. It represents a bold break from the status quo of 30+ year old pump designs.
2021 | Sep 16
Ivenix, a company founded by Pneuma CEO Jeffrey Carlisle, has been acquired by a market leader seeking a foothold in the US. It represents a bold break from the status quo of 30+ year old pump designs.